Replimune
-$0.50 (-2.36%) Today
$0.00 (0.00%) As of 9:01 AM UTC after-hours
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Replimune and other ETFs, options, and stocks.
About REPL
Replimune Group, Inc. is a clinical-stage biotechnology company, which engages in the development of oncolytic immunotherapy product candidates through immulytic platform. Its product candidates include RP1, RP2, and RP3.
CEO
Philip Astley-Sparke
Employees
152
Headquarters
Woburn, Massachusetts
Founded
2015
REPL Key Statistics
Market cap
970.70M
Price-Earnings ratio
—
Dividend yield
—
Average volume
241.45K
High today
$21.16
Low today
$20.04
Open price
$20.74
Volume
166.08K
52 Week high
$46.64
52 Week low
$19.39
Analyst ratings
100%
of 10 ratings
Buy
100%
Hold
0%
Sell
0%
REPL Earnings
-$1.75
-$1.17
-$0.58
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
— per share
Actual
Expected Feb 3, Pre-Market